PCR, POC testing, CRISPR diagnostics, immunoassays. Many tests much confusion. Thankfully, Nature Biotechnology and theFinancial Times bring some clarity on fast, portable tests to curb coronavirus pandemic.
It is Science but it could be mistaken for The CRISPR Journal. The latest issue indeed runs three papers by three CRISPR aces – David Liu, Jennifer Doudna, and Feng Zhang – about the cutting-edge fields of biological recorders and advanced diagnostic tests. Continue reading →